People in the News

Apr 27, 2017

Tina Nova

OpGen has appointed Tina Nova to its board of directors. Nova currently serves as president and CEO of newly formed molecular diagnostics company Molecular Stethoscope, and most recently served as senior vice president and general manager of Illumina's oncology business unit. From 2000 to 2014, Nova was cofounder, director, president, and CEO of Genoptix Medical Laboratory, which was purchased by Novartis for nearly $500,000 in 2011. She has also held senior positions with Nanogen, Ligand Pharmaceuticals, and Hybritech. She currently serves on the board of Arena Pharmaceuticals and Veracyte, and is vice chairman of the board for the newly formed Rady Pediatric Genomics and Systems Medicine Institute.

Apr 26, 2017

Rich Gray

N-of-One has appointed Rich Gray as VP of business development. In this position, he will lead both direct and channel sales teams to further develop channel partnerships to provide clinical interpretation on a broader scale. Gray joins N-of-One after serving various executive sales and market roles at organization such as Altos, now part of Flatiron Health; IntelliDose division of IntrinsiQ, now a division of AmerisourceBergen; and Medical Systems Management, now part of Optum.

Apr 26, 2017

Jamie L’Heureux

Progeny Genetics, a Delray Beach, Fla-based subsidiary of Ambry Genetics, has promoted Jamie L’Heureux to CEO. L'Heureux had been a software project manager at the company since 2014 and was a contractor for Progeny for two years before than. She has a total of 12 years of experience as a board-certified genetic counselor.

Apr 25, 2017

Vicki DiFrancesco

Xifin has appointed Vicki DiFrancesco its chief strategy officer. DiFrancesco has more than 25 years of experience in executive leadership positions and was most recently president and CEO of Pathology Inc., a women's health laboratory acquired by Laboratory Corporation of America last year. 

Apr 20, 2017

Bill Bonello

NeoGenomics has appointed Bill Bonello as VP, treasurer, and director of corporate development. Prior to joining NeoGenomics, Bonello served as senior research analyst at Craig Hallum Capital Markets, and as senior research analyst for RBC Capital Markets. He has also served as senior VP of investor relations for Laboratory Corporation of America, managing director of equity research at Wachovia Capital Markets, and managing director of equity research at Piper Jaffray.

Apr 18, 2017

Mark Boguski

Inspirata has appointed Mark Boguski to the role of chief medical officer for precision medicine. He will oversee strategic planning and implementation of the firm's precision medicine solutions. Prior to joining Inspirata in September 2016, Boguski served as CMO and cofounder of Precision Medicine Network, where he created a molecular oncology knowledge visualization and decision support platform called Crosswalk Insight: Oncology.

Apr 17, 2017

Jordan Hubbard

Jordan Hubbard has joined Two Pore Guys as vice president of engineering, where he will oversee the development of software and hardware for the company's nanopore-based single-molecule biosensor. Previously, Hubbard served as a manager and director of engineering at Apple, and headed up the FreeBSD project, an open-source UNIX variant that became a core technology in Apple's products.

Apr 13, 2017

David Schenkein

David  Schenkein has told the board of Foundation Medicine he will not stand for reelection during the company's annual shareholders' meeting. He will retire from the board effective as of the date of the meeting. Schenkein is a member of the audit committee.
Apr 12, 2017

Patrick Balthrop

Agendia has appointed Patrick Balthrop, former CEO of Luminex, as non-executive chairman. Balthrop is a director at Oxford Immunotec, Personalis, and Concert Genetics. He's also an advisor to Water Street Healthcare Partners and the Founding Principal of Apalachee Ventures, an investment and advisory firm. 

Apr 05, 2017

Alister Reynolds

Alister Reynolds has agreed to become CEO of SomaLogic. He is replacing Byron Hewett, who is stepping down. Reynolds has been on the company's board since 2003, and has held senior executive positions at Quest Diagnostics and its predecessor Corning.

Apr 05, 2017

Vishal Sikri

Vishal Sikri was appointed the general manager of Biocartis' US subsidiary, Biocartis US. Sikri was managing director and VP of commercial operations at Sysmex Inostics, the molecular diagnostics division of Sysmex, where he held other various roles. Prior to Sysmex, he held different senior product management positions at Abbott Laboratories. 

Apr 04, 2017

Erik Phelps

Tempus has hired Erik Phelps as executive VP and general counsel. He will be responsible for general corporate matters, strategy, and several other legal areas. Phelps comes to Tempus from electronic health records maker Epic Systems, where he also served as general counsel. He holds a JD from George Washington University Law School.

Apr 03, 2017

James Heath

The Institute for Systems Biology named James Heath its new president, effective January 2018. The current President and ISB Cofounder Lee Hood will remain on the institute's board. Heath is the Elizabeth W. Gilloon professor of chemistry at the California Institute of Technology, and a professor of molecular and medical pharmacology and codirector of the Parker Institute for Cancer Immunotherapy at the University of California, Los Angeles. He also is director of the NanoSystems Biology Cancer Center, which is funded by the National Cancer Institute. 

Mar 30, 2017

Joshua LaBaer

Joshua LaBaer has been appointed the executive director of the Biodesign Institute at Arizona State University, effective April 1. He was formerly at Harvard before joining ASU in 2009 to lead personalized medicine efforts at the institute as the university's first Virginia G. Piper Chair of Personalized Medicine, and director of the Biodesign Virginia G. Piper Center for Personalized Diagnostics. 

Mar 30, 2017

Michael Knell, Anthony Mattacchione

Bruker VP of Finance and Chief Accounting Officer Michael Knell announced he is resigning from the firm, effective April 21, in order to pursue other opportunities. Bruker CFO and Senior VP Anthony Mattacchione has assumed Knell's responsibilities as the company's principal accounting officer.

Mar 29, 2017

Alex Forrest-Hay

Metabolon has appointed Alex Forrest-Hay as VP of population health. In this position, Forrest-Hay will focus on the company's plans to expand its efforts to apply metabolomics to large population health studies. Before joining Metabolon, Forrest-Hay served as director of business development at Affymetrix. Prior to his work at Affymetrix, he served as a genomics specialist at Beckman Coulter and worked as a researcher at the University of Keele.

Mar 29, 2017

Anthony Gregg, Laurie Demmer, Elaine Lyon, Catherine Rehder

The American College of Medical Genetics has appointed Anthony Gregg as president-elect, Laurie Demmer as clinical genetics director, Elaine Lyon as laboratory molecular genetics director, and Catherine Rehder as laboratory cytogenetics director. It has also appointed Gregg, Demmer, Lyon, and Rehder to its board of directors. Gregg is currently a professor and chief of maternal-fetal medicine at the University of Florida. He also serves as the director of obstetrics at UF Health and program director of the Maternal-Fetal Medicine Fellowship. Demmer is a clinical geneticist and associate pediatric residency program director at Levine Children's Hospital/Carolinas Health Care. Lyon is currently a tenured professor of pathology at the University of Utah, and serves as chair of the departmental academic committee responsible for the department's faculty appointment. Rehder is currently the director of Duke University's Cytogenetics Laboratory and associate director of the Duke Molecular Diagnostics Laboratory.

Mar 27, 2017

Nicolas Barthelemy, Carlos Paya

Fluidigm said this week that it has appointed Nicolas Barthelemy and Carlos Paya to its board of directors. Barthelemy most recently served as president and CEO of molecular diagnostics firm Biotheranostics. He previously served as president of global commercial operations at Life Technologies and has also led the firm's cell systems division. He also serves on the board of directors of Repligen. Paya is president, CEO, and director of immunotherapy firm Immune Design. He formerly served as president of pharmaceutical firm Elan, and was VP of Lilly Research Laboratories.

Mar 23, 2017

Michael Hanbury

Acuamark Diagnostics has appointed Michael Hanbury to its board of directors. Hanbury is currently a healthcare advisor for the Pritzker Group and is on a number of medical device company boards. Previously, he served as VP of laboratory operations and laboratory excellence for Quest Diagnostics, and president and chief operating officer at Solstas Lab Partners. Earlier in his career he served as president and CEO of DCL Medical Laboratories, and as executive VP of operations and CSO at Unilab.

Mar 22, 2017

Jerry Williamson

Kew has appointed Jerry Williamson president, CEO, and board member. Williamson most recently served as president and CEO of Metamark Genetics. He has also held senior leadership positions at Flagship Ventures, which was later sold to Danaher; Biacore, which was later sold to GE Life Sciences; and Pyrosequencing.

Mar 22, 2017

Grace Terrell

Envision Genomics has appointed Grace Terrell as founding CEO. Terrell most recently served as the founder and strategist for Cornerstone Health Enablement Strategic Solutions, which she founded in 2012. She concurrently served as CEO of Cornerstone Health Care from 2000 to 2016, and is a practicing internist at Cornerstone Health Care.

Mar 22, 2017

Elizabeth Jaffe

The American Association for Cancer Research has elected Elizabeth Jaffe as its president for 2017-2018. Jaffe is currently a chair and member of the National Cancer Advisory Board for the National Cancer Institute, and co-chair of the NCI Blue Ribbon Panel for the National Cancer Moonshot Initiative. She is also the deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, the associate director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, professor of oncology and professor of pathology at Johns Hopkins School of Medicine, and an active staff member in oncology at Johns Hopkins Hospital.

Mar 21, 2017

David Heckerman

David Heckerman has joined Human Longevity as chief data scientist. He will report to Co-Founder Craig Venter and will lead a team analyzing large-scale medical and genomic data. Heckerman comes to HLI from Microsoft, where he worked for more than 25 years. He led that company's first research team focused on machine learning and helped produce the first content-based spam filter. More recently, he led Microsoft Genomics, including Microsoft's cloud computing services for genomics. Heckerman has held adjunct faculty and visiting scholar positions at a number of institutions, including the University of California, Los Angeles, the University of Washington, and Columbia University. He holds a medical degree and a doctorate in computer science, both from Stanford University.

Mar 20, 2017

Samraat Raha

Agilent Technologies has named Samraat Raha senior VP of strategy and corporate development. Raha will report directly to Agilent President and CEO Mike McMullen. His duties will include advising the firm's executive team and developing its global growth strategy, including for mergers and acquisitions. Raha joins Agilent from Illumina, where was VP of global marketing. He also served as VP and general manager of genomic assays at Life Technologies, where he helmed the TaqMan and qPCR product lines.

Mar 17, 2017

Kim Popovits, Wendy Yarno

MyoKardia has appointed Kim Popovits and Wendy Yarno to its board of directors. Popovitz currently serves on the boards of the American Clinical Laboratory Association, California Life Sciences Association, Personalized Medicine Coalition, and ZS Pharma. She has served as Genomic Health's CEO and president since 2009, and chairman of the company's board since 2013. Yarno is the non-executive chairman of the board of Aratana Therapeutics and has served on the boards of ADial PHarmaceuticals, Durata Therapeutics, Medivation, St. Jude Medical, and PluroGen Therapeutics. She is also a retired chief marketing officer for Merck.

Pages

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.